Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Gilead Sciences, Inc.(GILD) | 292,959 | 359,025 | +66,066 | $20.10M | $30.10M | 8.88% | +$10.00M |
| Bristol-Myers Squibb Company(BMY) | 0 | 574,057 | +574,057 | $0 | $29.70M | 8.77% | +$29.70M |
| Royalty Pharma plcCL A(RPRX) | 692,300 | 664,859 | -27,441 | $18.26M | $18.81M | 5.55% | +$552.9K |
| Agilent Technologies, Inc.(A) | 0 | 120,485 | +120,485 | $0 | $17.89M | 5.28% | +$17.89M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 365,000 | 286,803 | -78,197 | $15.00M | $15.93M | 4.70% | +$930.4K |
| Legend Biotech CorporationADS(LEGN) | 343,130 | 325,953 | -17,177 | $15.20M | $15.88M | 4.69% | +$686.5K |
| Insmed Incorporated(INSM) | 227,637 | 215,884 | -11,753 | $15.25M | $15.76M | 4.65% | +$507.9K |
| Eli Lilly and Company(LLY) | 0 | 17,299 | +17,299 | $0 | $15.33M | 4.52% | +$15.33M |
| Regeneron Pharmaceuticals, Inc.(REGN) | 0 | 14,476 | +14,476 | $0 | $15.22M | 4.49% | +$15.22M |
| Harmony Biosciences Holdings, Inc.(HRMY) | 295,771 | 376,315 | +80,544 | $8.92M | $15.05M | 4.44% | +$6.13M |
| Perrigo Company plcSHS(PRGO) | 100,000 | 557,937 | +457,937 | $2.57M | $14.63M | 4.32% | +$12.07M |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 0 | 117,500 | +117,500 | $0 | $13.09M | 3.86% | +$13.09M |
| Springworks Therapeutics Inc | 0 | 378,453 | +378,453 | $0 | $12.13M | 3.58% | +$12.13M |
| Viridian Therapeutics, Inc.(VRDN) | 0 | 518,677 | +518,677 | $0 | $11.80M | 3.48% | +$11.80M |
| Sarepta Therapeutics, Inc.(SRPT) | 89,379 | 83,756 | -5,623 | $14.12M | $10.46M | 3.09% | -$3.66M |
| BridgeBio Pharma, Inc.(BBIO) | 311,700 | 396,388 | +84,688 | $7.90M | $10.09M | 2.98% | +$2.20M |
| Axsome Therapeutics, Inc.(AXSM) | 0 | 105,767 | +105,767 | $0 | $9.51M | 2.81% | +$9.51M |
| Agios Pharmaceuticals, Inc.(AGIO) | 0 | 186,623 | +186,623 | $0 | $8.29M | 2.45% | +$8.29M |
| Iovance Biotherapeutics, Inc.(IOVA) | 0 | 876,009 | +876,009 | $0 | $8.23M | 2.43% | +$8.23M |
| Intellia Therapeutics, Inc.(NTLA) | 0 | 390,622 | +390,622 | $0 | $8.03M | 2.37% | +$8.03M |
| Vera Therapeutics, Inc.CL A(VERA) | 230,000 | 172,876 | -57,124 | $8.32M | $7.64M | 2.26% | -$680.3K |
| Arcellx Inc COMMON STOCK | 187,000 | 89,863 | -97,137 | $10.32M | $7.50M | 2.22% | -$2.82M |
| Avidity Biosciences Inc | 0 | 160,947 | +160,947 | $0 | $7.39M | 2.18% | +$7.39M |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 1,975,298 | 798,137 | -1,177,161 | $12.21M | $6.07M | 1.79% | -$6.14M |
| Enliven Therapeutics Inc | 222,985 | 207,896 | -15,089 | $5.21M | $5.31M | 1.57% | +$98.5K |
| Avadel Pharmaceuticals Plc | 733,001 | 385,172 | -347,829 | $10.31M | $5.05M | 1.49% | -$5.25M |
| Ionis Pharmaceuticals, Inc.(IONS) | 160,166 | 97,300 | -62,866 | $7.63M | $3.90M | 1.15% | -$3.74M |
| Amgen Inc.(AMGN) | 64,201 | 0 | -64,201 | $20.06M | $0 | — | -$20.06M |
| Avantor, Inc.(AVTR) | 400,000 | 0 | -400,000 | $8.48M | $0 | — | -$8.48M |
| Biogen Inc.(BIIB) | 76,726 | 0 | -76,726 | $17.79M | $0 | — | -$17.79M |
| BioMarin Pharmaceutical Inc.(BMRN) | 273,533 | 0 | -273,533 | $22.52M | $0 | — | -$22.52M |
| CRISPR Therapeutics AGNAMEN AKT(CRSP) | 201,497 | 0 | -201,497 | $10.88M | $0 | — | -$10.88M |
| Cytokinetics, Incorporated(CYTK) | 236,900 | 0 | -236,900 | $12.84M | $0 | — | -$12.84M |
| Evolus, Inc.(EOLS) | 465,300 | 0 | -465,300 | $5.05M | $0 | — | -$5.05M |
| Kenvue Inc.(KVUE) | 960,400 | 0 | -960,400 | $17.46M | $0 | — | -$17.46M |
| Merck & Co., Inc.(MRK) | 175,600 | 0 | -175,600 | $21.74M | $0 | — | -$21.74M |
| Pfizer Inc.(PFE) | 185,200 | 0 | -185,200 | $5.18M | $0 | — | -$5.18M |
| Teva Pharmaceutical Industries LimitedADS(TEVA) | 911,900 | 0 | -911,900 | $14.82M | $0 | — | -$14.82M |